Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback